American Society of Hospital Pharmacists. ASHP technical assistance bulletin on handling cytotoxic and hazardous drugs. Am J Hosp Pharm1990; 47: 1033–49.
2.
Van RaalteJRiceCMossCE. Visible-light system for detecting doxorubicin contamination on skin and surfaces. Am J Hosp Pharm1990; 47: 1067–74.
3.
CastegnaroMAdamsJArmourMABarekJBenvenutoJConfalonieriC, eds, Laboratory decontamination and destruction of carcinogens in laboratory wastes: some antineoplastic agents. Lyon: WHO/International Agency for Research in Cancer. IARC Scientific Publication 73, 1985.
4.
MonteithDKConnorTHBenvenutoJAFairchildEJ. Theiss Je. Stability and inactivation of mutagenic drugs and their metabolites in the urine of patients administered antineoplastic therapy. Environ Mol Mutagen1987; 10: 341–56.
5.
LunnGSansoneEBAndrewsAWHellwigLC. Degradation and disposal of some antineoplastic drugs. J Pharm Sci1989; 78: 652–9.
6.
JohnsonEGJanosikJE. Manufacturers' recommendations for handling spilled antineoplastic agents. Am J Hosp Pharm1989; 46: 318–9.
7.
DorrRTAlbertsDS. Topical absorption and inactivation of cytotoxic anticancer agents in vitro. Cancer1992; 70 (suppl 4): 983–7.
8.
BenvenutoJAConnorTHMonteithDKLaidlawJLAdamsSCMatneyTSDegradation and inactivation of antitumor drugs. J Pharm Sci1993; 82: 988–91.
9.
McDiarmidMAGurleyHTArringtonD. Pharmaceuticals as hospital hazards: managing the risks. J Occup Med1991; 33: 155–8.
